2025-08-13 |
13G/A
|
PYPD / PolyPid Ltd.
|
|
4,081,088 |
5,762,349 |
|
|
|
2025-08-13 |
13G/A
|
US49721T1016 / KIORA PHARMACEUTICALS INC
|
|
715,231 |
464,676 |
|
|
|
2025-08-12 |
13G/A
|
|
|
|
570,326 |
|
|
|
2025-08-11 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
343,781 |
0 |
|
|
|
2025-08-11 |
13G/A
|
MYO / Myomo, Inc.
|
|
7,279,046 |
7,359,046 |
|
|
|
2025-08-11 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
9,713,171 |
10,987,104 |
|
|
|
2025-08-11 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
9,886,969 |
14,432,072 |
|
|
|
2025-08-11 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
9,713,171 |
10,987,104 |
|
|
|
2025-08-11 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
9,713,171 |
10,987,104 |
|
|
|
2025-05-13 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
9,962,649 |
9,886,969 |
|
|
|
2025-05-12 |
13G/A
|
|
|
|
670,158 |
|
|
|
2025-05-12 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
964,587 |
343,781 |
|
|
|
2025-05-12 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
9,933,964 |
9,713,171 |
|
|
|
2025-05-12 |
13G/A
|
MYO / Myomo, Inc.
|
|
7,574,330 |
7,279,046 |
|
|
|
2025-05-12 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
6,659,993 |
6,674,993 |
|
|
|
2025-04-11 |
13G
|
TLPH / Talphera, Inc.
|
|
|
7,642,515 |
|
|
|
2025-02-14 |
13G/A
|
PYPD / PolyPid Ltd.
|
|
|
4,081,088 |
|
|
|
2025-02-13 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
750,000 |
1,062,500 |
|
|
|
2025-02-13 |
13G/A
|
SPRB / Spruce Biosciences, Inc.
|
|
0 |
0 |
|
|
|
2025-02-12 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
426,002 |
9,962,649 |
|
|
|
2025-02-11 |
13G/A
|
|
|
628,050 |
791,315 |
|
|
|
2025-02-10 |
13G/A
|
PYPD / PolyPid Ltd.
|
|
679,168 |
4,085,588 |
|
|
|
2025-02-10 |
13G/A
|
US49721T1016 / KIORA PHARMACEUTICALS INC
|
|
2,300,000 |
715,231 |
|
|
|
2025-02-07 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
|
964,587 |
|
|
|
2025-02-07 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
2,514,046 |
9,933,964 |
|
|
|
2025-02-04 |
13G/A
|
MYO / Myomo, Inc.
|
|
3,021,391 |
7,574,330 |
|
|
|
2025-02-03 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
3,671,550 |
7,472,745 |
|
|
|
2025-01-27 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
2,763,468 |
6,659,993 |
|
|
|
2024-12-02 |
13D
|
NRXS / NeurAxis, Inc.
|
|
|
2,100,840 |
|
|
|
2024-12-02 |
13G
|
NRXS / NeurAxis, Inc.
|
|
|
2,100,840 |
|
|
|
2024-11-14 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
2,763,468 |
2,763,468 |
|
|
|
2024-11-14 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
2,763,468 |
2,763,468 |
|
|
|
2024-11-06 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
495,490 |
426,002 |
|
|
|
2024-10-28 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
2,513,641 |
2,514,046 |
|
|
|
2024-10-23 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
504,261 |
495,490 |
|
|
|
2024-10-23 |
13G/A
|
PYPD / PolyPid Ltd.
|
|
679,688 |
679,168 |
|
|
|
2024-10-23 |
13G/A
|
MDWD / MediWound Ltd.
|
|
513,490 |
628,050 |
|
|
|
2024-10-23 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
1,391,577 |
750,000 |
|
|
|
2024-10-23 |
13G/A
|
SPRB / Spruce Biosciences, Inc.
|
|
1,508,419 |
0 |
|
|
|
2024-10-18 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
7,547,148 |
8,287,503 |
|
|
|
2024-10-18 |
13G/A
|
MYO / Myomo, Inc.
|
|
2,664,999 |
3,021,391 |
|
|
|
2024-08-14 |
13G/A
|
PYPD / PolyPid Ltd.
|
|
415,800 |
679,688 |
|
|
|
2024-08-14 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
2,709,516 |
3,671,550 |
|
|
|
2024-07-11 |
13G/A
|
MYO / Myomo, Inc.
|
|
2,447,740 |
2,664,999 |
|
|
|
2024-07-11 |
13G/A
|
MYO / Myomo, Inc.
|
|
2,447,740 |
2,664,999 |
|
|
|
2024-07-11 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
926,016 |
1,391,577 |
|
|
|
2024-07-11 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
2,492,765 |
2,513,641 |
|
|
|
2024-07-11 |
13G/A
|
MDWD / MediWound Ltd.
|
|
485,990 |
513,490 |
|
|
|
2024-07-11 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
3,305,936 |
2,709,516 |
|
|
|
2024-05-29 |
13G
|
US49721T1016 / KIORA PHARMACEUTICALS INC
|
|
|
2,300,000 |
|
|
|
2024-05-29 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
4,541,489 |
7,547,148 |
|
|
|
2024-05-29 |
13G
|
US49721T1016 / KIORA PHARMACEUTICALS INC
|
|
|
2,300,000 |
|
|
|
2024-05-29 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
504,261 |
504,261 |
|
|
|
2024-05-17 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
1,371,126 |
2,492,765 |
|
|
|
2024-05-17 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
1,151,907 |
2,763,468 |
|
|
|
2024-04-25 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
1,488,400 |
3,305,936 |
|
|
|
2024-04-25 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
2,499,993 |
926,016 |
|
|
|
2024-04-25 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
989,940 |
1,371,126 |
|
|
|
2024-04-25 |
13G/A
|
MDWD / MediWound Ltd.
|
|
479,990 |
485,990 |
|
|
|
2024-04-25 |
13G/A
|
MYO / Myomo, Inc.
|
|
2,433,740 |
2,447,740 |
|
|
|
2024-04-25 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
4,885,580 |
4,541,489 |
|
|
|
2024-04-25 |
13G/A
|
SPRB / Spruce Biosciences, Inc.
|
|
2,322,000 |
1,508,419 |
|
|
|
2024-03-25 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
1,098,143 |
1,151,907 |
|
|
|
2024-03-20 |
13G
|
BFRI / Biofrontera Inc.
|
|
504,261 |
504,261 |
|
|
|
2024-03-20 |
13G
|
BFRI / Biofrontera Inc.
|
|
|
504,261 |
|
|
|
2024-03-01 |
13G
|
PYPD / PolyPid Ltd.
|
|
|
415,800 |
|
|
|
2024-02-22 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
6,435,000 |
4,885,580 |
|
|
|
2024-02-20 |
13G/A
|
GTHP / Guided Therapeutics, Inc.
|
|
2,338,740 |
0 |
|
|
|
2024-02-20 |
13G/A
|
SIENQ / Sientra, Inc.
|
|
509,274 |
0 |
|
|
|
2024-02-14 |
13G/A
|
MYO / Myomo, Inc.
|
|
2,661,418 |
2,433,740 |
|
|
|
2024-02-14 |
13G/A
|
MYO / Myomo, Inc.
|
|
2,661,418 |
2,433,740 |
|
|
|
2024-02-14 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
|
989,940 |
|
|
|
2024-02-14 |
13G/A
|
MDWD / MediWound Ltd.
|
|
444,326 |
479,990 |
|
|
|
2024-02-14 |
13G/A
|
MDWD / MediWound Ltd.
|
|
444,326 |
479,990 |
|
|
|
2024-02-14 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
986,293 |
1,488,400 |
|
|
|
2024-01-30 |
13G
|
SPRB / Spruce Biosciences, Inc.
|
|
|
2,322,000 |
|
|
|
2023-11-28 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
701,500 |
1,098,143 |
|
|
|
2023-08-28 |
13G/A
|
MYO / Myomo, Inc.
|
|
553,290 |
2,661,418 |
|
|
|
2023-07-28 |
13G
|
OPTN / OptiNose, Inc.
|
|
6,435,000 |
6,435,000 |
|
|
|
2023-06-08 |
13G
|
NSPR / InspireMD, Inc.
|
|
|
1,860,405 |
|
|
|
2023-02-15 |
13G
|
SIENQ / Sientra, Inc.
|
|
|
509,274 |
|
|
|
2023-02-15 |
13G
|
TRVI / Trevi Therapeutics, Inc.
|
|
2,185,664 |
2,499,993 |
|
|
|
2023-02-14 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
605,228 |
986,293 |
|
|
|
2022-12-21 |
13G
|
MDWD / MediWound Ltd.
|
|
|
444,326 |
|
|
|
2022-12-21 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
701,500 |
701,500 |
|
|
|
2022-11-03 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
6,052,282 |
605,228 |
|
|
|
2022-07-21 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
423,500 |
701,500 |
|
|
|
2022-07-06 |
13G
|
GTHP / Guided Therapeutics, Inc.
|
|
|
2,338,740 |
|
|
|
2022-03-09 |
13G
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
2,185,664 |
|
|
|
2022-03-09 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
406,500 |
423,500 |
|
|
|
2022-02-14 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
406,500 |
406,500 |
|
|
|
2022-02-14 |
13G/A
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
2,607,857 |
707,467 |
|
|
|
2022-02-14 |
13G/A
|
PLXP / PLx Pharma Inc.
|
|
970,425 |
0 |
|
|
|
2022-02-11 |
13G
|
GRTX / Galera Therapeutics, Inc.
|
|
|
1,543,783 |
|
|
|
2022-01-21 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
3,207,160 |
6,052,282 |
|
|
|
2022-01-20 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
812,555 |
969,484 |
|
|
|
2022-01-20 |
13G/A
|
MYO / Myomo, Inc.
|
|
365,900 |
553,290 |
|
|
|
2022-01-07 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
653,438 |
|
|
|
2021-09-23 |
13G
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
812,555 |
|
|
|
2021-07-08 |
13G
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
3,207,160 |
|
|
|
2021-06-25 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
406,500 |
406,500 |
|
|
|
2021-05-19 |
13G
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
|
2,607,857 |
|
|
|
2021-05-19 |
13G
|
MYO / Myomo, Inc.
|
|
|
365,900 |
|
|
|
2021-04-06 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
701,500 |
406,500 |
|
|
|
2021-01-22 |
13G/A
|
PLXP / PLx Pharma Inc.
|
|
970,425 |
970,425 |
|
|
|
2021-01-22 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
4,000,000 |
5,377,113 |
|
|
|
2020-12-18 |
13G
|
PLXP / PLx Pharma Inc.
|
|
|
970,425 |
|
|
|
2020-09-18 |
13G
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
4,000,000 |
|
|
|
2020-05-14 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
853,950 |
701,500 |
|
|
|
2020-04-10 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
853,950 |
853,950 |
|
|
|
2020-04-09 |
13D/A
|
DCTH / Delcath Systems, Inc.
|
|
853,950 |
853,950 |
|
|
|
2020-03-12 |
13D
|
DCTH / Delcath Systems, Inc.
|
|
853,950 |
853,950 |
|
|
|
2020-03-11 |
13D
|
DCTH / Delcath Systems, Inc.
|
|
853,950 |
853,950 |
|
|
|
2020-03-06 |
13G/A
|
DCTH / Delcath Systems, Inc.
|
|
468,452 |
853,950 |
|
|
|
2020-02-13 |
13G/A
|
DCTH / Delcath Systems, Inc.
|
|
280,000,000 |
468,452 |
|
|
|
2019-08-01 |
13G
|
DCTH / Delcath Systems, Inc.
|
|
|
280,000,000 |
|
|
|
2019-07-24 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
2,003,478 |
936,651 |
|
|
|
2019-02-15 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
2,003,478 |
2,003,478 |
|
|
|
2019-02-15 |
13G/A
|
H03579101 / Auris Medical Holding Ltd
|
|
420,000 |
420,000 |
|
|
|
2019-02-14 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
594,077 |
40,169 |
|
|
|
2019-02-14 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
3,332,292 |
0 |
|
|
|
2019-02-14 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
1,459,100 |
2,003,478 |
|
|
|
2019-02-14 |
13G/A
|
H03579101 / Auris Medical Holding Ltd
|
|
2,050,489 |
420,000 |
|
|
|
2018-11-23 |
13G
|
US16706W1027 / Chiasma Inc
|
|
1,459,100 |
1,459,100 |
|
|
|
2018-11-21 |
13G
|
US16706W1027 / Chiasma Inc
|
|
|
1,459,100 |
|
|
|
2018-08-10 |
13G
|
H03579101 / Auris Medical Holding Ltd
|
|
|
2,050,489 |
|
|
|
2018-05-15 |
13G/A
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
1,105,600 |
541,600 |
|
|
|
2018-02-14 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
594,077 |
594,077 |
|
|
|
2018-02-09 |
13G/A
|
PSDV / pSivida Corp.
|
|
2,126,800 |
2,235,355 |
|
|
|
2018-02-09 |
13G/A
|
ZSAN / Zosano Pharma Corp
|
|
2,083,100 |
32,500 |
|
|
|
2018-02-01 |
13G
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
|
1,105,600 |
|
|
|
2018-01-02 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
2,105,626 |
3,332,292 |
|
|
|
2017-07-24 |
13G
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
2,105,626 |
|
|
|
2017-04-07 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
2,220,055 |
594,077 |
|
|
|
2017-04-07 |
13G
|
PSDV / pSivida Corp.
|
|
|
2,126,800 |
|
|
|
2017-03-29 |
13G/A
|
ZSAN / Zosano Pharma Corp
|
|
2,083,100 |
2,083,100 |
|
|
|
2017-03-28 |
13G/A
|
ZSAN / Zosano Pharma Corp
|
|
2,023,777 |
2,083,100 |
|
|
|
2016-11-30 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
2,220,055 |
|
|
|
2016-11-16 |
13G
|
ZSAN / Zosano Pharma Corp
|
|
|
2,023,777 |
|
|
|
2016-02-16 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
3,592,889 |
590,590 |
|
|
|
2015-08-26 |
13G
|
ALBO / Albireo Pharma Inc
|
|
2,883,313 |
3,592,889 |
|
|
|
2015-04-23 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
2,883,313 |
|
|
|
2014-10-24 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
1,265,492 |
|
|
|